A detailed history of Integrated Quantitative Investments LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Integrated Quantitative Investments LLC holds 20,673 shares of AXGN stock, worth $374,801. This represents 0.17% of its overall portfolio holdings.

Number of Shares
20,673
Holding current value
$374,801
% of portfolio
0.17%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$12.47 - $17.19 $257,792 - $355,368
20,673 New
20,673 $341 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $767M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Integrated Quantitative Investments LLC Portfolio

Follow Integrated Quantitative Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Quantitative Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Quantitative Investments LLC with notifications on news.